@davis

1 post audited · 6 claims analysed

Instagram profile

Science evidence grade

50%Moderate evidence grade

Based on 6 claims across 1 audit

SupportedOverstatedMisleadingNo Evidence

3

Supported

50%

0

Overstated

0%

0

Misleading

0%

3

No Evidence

50%

Share this evidence grade

Claim-level evidence grades — not a character judgment. Methodology · Right of reply · Leaderboards

What @davis claims actually are

We separate claims into three buckets: backed by evidence, factually incorrect, and grey — like animal-only findings sold as human fact (e.g. BPC-157 “fixes Achilles” from rat studies).

Evidence-based

50%

3 claims

Claims that align with published human or clinical evidence at the stated strength.

Ex: “Semaglutide can reduce body weight in adults with obesity” — supported by large RCTs.

Factually incorrect

0%

0 claims

Claims that conflict with the evidence, invent certainty, or omit critical safety/context in a misleading way.

Ex: “Peptides have no side effects” — contradicts known adverse-event profiles.

Grey / overstated

50%

3 claims

Plausible direction but wrong certainty — animal-only data sold as human fact, dose/effect overstated, or no adequate published support yet.

Ex: “BPC-157 fixes Achilles tears” — often rests on rodent tendon models, not proven human Achilles repair trials.

Evidence mix

Share of audited claims in each bucket

Loading…
BackedIncorrectGrey

Verdict detail

Grey splits into overstated (wrong certainty) vs no published support

Loading…

Claims over time

Stacked by bucket as audits land — plus the running evidence grade

Loading…

Gold line = running science evidence grade (Supported + ½ Overstated ÷ total claims).

Audit history(1 post)

Post thumbnail
✅ Supported
Audited Oct 2, 2026·about 18 hours ago·View source

“davistalkspepss on October 1, 2026”

The causal chain linking Retiface to facial puffiness via vasopressin remains entirely unvalidated. While Claims 3 and 6 rely on established mechanisms (GLP-1 effects on appetite; vasopressin-mediated water reabsorption), the intermediate steps (Claims 1, 2, 4, 5) lack direct scientific support. The claim that Retiface activates GLP-1 receptors is unproven, and the mechanistic link from appetite suppression → water intake reduction → hypernatremia → vasopressin release → facial edema is composed of disconnected assertions with no integrated evidence in the literature. Without validation of the foundational claims (Retiface identity, GLP-1 activation, and appetite-hydration coupling), the overall premise cannot be endorsed.

Audit another post from @davis

Paste their social post link to add a new audit

New audit